Muscle biochemical and pathological diagnosis in Pompe disease

Background and objectives Pompe disease is reportedly less prevalent in Japan than in neighbouring countries, raising a possibility that some patients may be overlooked. Therefore, all muscle biopsy samples received at our institute were screened for Pompe disease to determine the accuracy of the disease prevalence. Methods The acid α-glucosidase (GAA) activity was assayed using 10 µm frozen muscle sections from 2408 muscle biopsies received between July 2015 and January 2018. Genetic analysis was performed for samples with decreased activity. The number of myopathologically diagnosed patients was retrospectively assessed. Results The GAA activity was distributed similarly to previous results from dried blood spot screening. GAA activity measured using muscle sections corresponded to that measured using muscle blocks. Of 163 patients with GAA activity <3 nmol/hour/mg protein, 43 (26%) patients had homozygous pseudodeficiency alleles in GAA (p.G576S and p.E689K). In the retrospective analysis, the number of patients diagnosed with Pompe disease via muscle biopsies decreased to zero over time. Discussion Muscle pathology is an accurate method to diagnose Pompe disease. It is unlikely that a significant number of patients with Pompe disease are overlooked. Pathological variants were rare, and the majority carried a pseudodeficiency allele, which further supports our conclusion.

[1]  F. Endo,et al.  Current status of newborn screening for Pompe disease in Japan , 2021, Orphanet Journal of Rare Diseases.

[2]  Jun Kido,et al.  Newborn Screening for Pompe Disease , 2020, International journal of neonatal screening.

[3]  F. Endo,et al.  Newborn screening for Pompe disease in Japan: report and literature review of mutations in the GAA gene in Japanese and Asian patients , 2019, Journal of Human Genetics.

[4]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[5]  H. Lv,et al.  Clinical and GAA gene mutation analysis in mainland Chinese patients with late-onset Pompe disease: identifying c.2238G > C as the most common mutation , 2014, BMC Medical Genetics.

[6]  I. Nonaka,et al.  Acid phosphatase-positive globular inclusions is a good diagnostic marker for two patients with adult-onset Pompe disease lacking disease specific pathology , 2012, Neuromuscular Disorders.

[7]  I. Nonaka,et al.  Effects of enzyme replacement therapy on five patients with advanced late-onset glycogen storage disease type II: a 2-year follow-up study , 2012, Journal of Inherited Metabolic Disease.

[8]  I. Nishino,et al.  Autophagy in Lysosomal Myopathies , 2012, Brain pathology.

[9]  Y. Chien,et al.  Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program. , 2010, Molecular genetics and metabolism.

[10]  F. Endo,et al.  High frequency of acid alpha-glucosidase pseudodeficiency complicates newborn screening for glycogen storage disease type II in the Japanese population. , 2009, Molecular genetics and metabolism.

[11]  S. Tsujino,et al.  Structural and biochemical studies on Pompe disease and a “pseudodeficiency of acid α-glucosidase” , 2007, Journal of Human Genetics.

[12]  A. Reuser,et al.  A new diagnostic assay for glycogen storage disease type II in mixed leukocytes. , 2006, Molecular genetics and metabolism.

[13]  David M. Rapoport,et al.  Pompe disease diagnosis and management guideline , 2006, Genetics in Medicine.

[14]  Wuh-Liang Hwu,et al.  A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. , 2006, The Journal of pediatrics.

[15]  F. Martiniuk,et al.  Identification of two subtypes of infantile acid maltase deficiency. , 2000, The Journal of pediatrics.

[16]  A. Pellicer,et al.  Isolation of a cDNA for human acid alpha-glucosidase and detection of genetic heterogeneity for mRNA in three alpha-glucosidase-deficient patients. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Tsujino,et al.  Structural and biochemical studies on Pompe disease and a "pseudodeficiency of acid alpha-glucosidase". , 2007, Journal of human genetics.